Scilex Holding Company (SCLX)
NASDAQ: SCLX · Real-Time Price · USD
6.87
-0.60 (-8.03%)
At close: Jun 22, 2026, 4:00 PM EDT
7.00
+0.13 (1.89%)
After-hours: Jun 22, 2026, 7:53 PM EDT
Scilex Holding Company Revenue
Scilex Holding Company had revenue of $8.61M in the quarter ending March 31, 2026, with 72.12% growth. This brings the company's revenue in the last twelve months to $33.86M, down -33.22% year-over-year. In the year 2025, Scilex Holding Company had annual revenue of $30.25M, down -46.54%.
Revenue (ttm)
$33.86M
Revenue Growth
-33.22%
P/S Ratio
1.43
Revenue / Employee
$995,941
Employees
34
Market Cap
48.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.25M | -26.34M | -46.54% |
| Dec 31, 2024 | 56.59M | 9.85M | 21.07% |
| Dec 31, 2023 | 46.74M | 8.71M | 22.90% |
| Dec 31, 2022 | 38.03M | 6.72M | 21.45% |
| Dec 31, 2021 | 31.32M | 7.76M | 32.92% |
| Dec 31, 2020 | 23.56M | 2.53M | 12.01% |
| Dec 31, 2019 | 21.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pfizer | 63.32B |
| Sanofi | 54.60B |
| Bristol-Myers Squibb Company | 48.48B |
| GSK plc | 43.29B |
| Biogen | 9.94B |
| Grifols | 8.58B |
| Organon & Co. | 6.16B |
| Amarin Corporation | 216.76M |
SCLX News
- 6 days ago - Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens to List on Biconomy Exchange as Early as June 23, 2026 - GlobeNewsWire
- 10 days ago - Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities - GlobeNewsWire
- 18 days ago - Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities - GlobeNewsWire
- 20 days ago - Scilex files to sell 2.08M shares of common stock - TheFly
- 20 days ago - Scilex files to sell 6.58M shares of common stock for holders - TheFly
- 20 days ago - Scilex Holding Company Registration statement: Registration filing - Filings
- 4 weeks ago - Scilex approves dividend of Semnur Pharmaceuticals shares - TheFly
- 4 weeks ago - Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026 - GlobeNewsWire